InsiderClue
Insiders · Profile

TRAVERSA SERGIO

Chief Executive Officer at RELMADA THERAPEUTICS · Director at Actinium Pharmaceuticals. Filing since 14 Dec 2015. CIK 0001565832

RLMD RELMADA THERAPEUTICS, INC. Chief Executive Officer · 34 trades ATNM Actinium Pharmaceuticals, Inc. Director · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
RLMD RELMADA THERAPEUTICS, INC.
10 Sep 2026
Chief Executive Officer
Bought
100,000
$410.00K
7.1%
RLMD RELMADA THERAPEUTICS, INC.
9 Sep 2026
Chief Executive Officer
Bought
100,000
$418.00K
7.7%
RLMD RELMADA THERAPEUTICS, INC.
15 Dec 2025
Chief Executive Officer
Bought
27,500
$113.30K
2.2%
RLMD RELMADA THERAPEUTICS, INC.
5 Nov 2025
Chief Executive Officer
Bought
272,500
$599.50K
27.3%
RLMD RELMADA THERAPEUTICS, INC.
28 Aug 2025
Chief Executive Officer
Bought
55,976
$41.42K
5.9%
RLMD RELMADA THERAPEUTICS, INC.
27 Aug 2025
Chief Executive Officer
Bought
129,455
$86.73K
15.9%
RLMD RELMADA THERAPEUTICS, INC.
26 Aug 2025
Chief Executive Officer
Bought
80,545
$49.94K
11.0%
RLMD RELMADA THERAPEUTICS, INC.
20 May 2025
Chief Executive Officer
Bought
147,686
$82.25K
25.2%
RLMD RELMADA THERAPEUTICS, INC.
19 May 2025
Chief Executive Officer
Bought
30,000
$14.99K
5.4%
RLMD RELMADA THERAPEUTICS, INC.
16 May 2025
Chief Executive Officer
Bought
172,314
$77.47K
44.9%
RLMD RELMADA THERAPEUTICS, INC.
11 Sep 2024
Chief Executive Officer
Bought
51,407
$153.71K
15.5%
RLMD RELMADA THERAPEUTICS, INC.
10 Sep 2024
Chief Executive Officer
Bought
33,014
$90.79K
11.0%
RLMD RELMADA THERAPEUTICS, INC.
9 Sep 2024
Chief Executive Officer
Bought
55,579
$150.62K
22.8%
RLMD RELMADA THERAPEUTICS, INC.
31 Jan 2024
Chief Executive Officer
Bought
27,460
$109.75K
12.7%
RLMD RELMADA THERAPEUTICS, INC.
30 Jan 2024
Chief Executive Officer
Bought
40,999
$159.95K
23.4%
RLMD RELMADA THERAPEUTICS, INC.
29 Jan 2024
Chief Executive Officer
Bought
31,541
$117.04K
21.9%
RLMD RELMADA THERAPEUTICS, INC.
8 Dec 2022
Chief Executive Officer
Bought
55,250
$115.80K
62.2%
RLMD RELMADA THERAPEUTICS, INC.
1 Jul 2022
Chief Executive Officer
Sold, plan not stated
13,755
$253.28K
13.4%
RLMD RELMADA THERAPEUTICS, INC.
30 Jun 2022
Chief Executive Officer
Sold, plan not stated
16,012
$306.30K
15.3%
RLMD RELMADA THERAPEUTICS, INC.
10 Mar 2021
CEO
Sold, plan not stated
2,983
$104.68K
3.3%
RLMD RELMADA THERAPEUTICS, INC.
9 Mar 2021
CEO
Sold, plan not stated
7,017
$250.17K
7.1%
RLMD RELMADA THERAPEUTICS, INC.
24 Feb 2021
CEO
Sold, plan not stated
10,000
$342.39K
10.1%
RLMD RELMADA THERAPEUTICS, INC.
11 Feb 2021
CEO
Sold, plan not stated
1,446
$51.24K
1.6%
RLMD RELMADA THERAPEUTICS, INC.
10 Feb 2021
CEO
Sold, plan not stated
1,930
$68.10K
2.1%
RLMD RELMADA THERAPEUTICS, INC.
9 Feb 2021
CEO
Sold, plan not stated
5,963
$209.94K
6.2%
RLMD RELMADA THERAPEUTICS, INC.
8 Feb 2021
CEO
Sold, plan not stated
3,313
$116.05K
3.3%
RLMD RELMADA THERAPEUTICS, INC.
3 Feb 2021
CEO
Sold, plan not stated
100
$3.50K
0.1%
RLMD RELMADA THERAPEUTICS, INC.
2 Feb 2021
CEO
Sold, plan not stated
3,178
$111.47K
3.5%
RLMD RELMADA THERAPEUTICS, INC.
27 Jan 2021
CEO
Sold, plan not stated
10,000
$323.91K
11.7%
RLMD RELMADA THERAPEUTICS, INC.
26 Jan 2021
CEO
Sold, plan not stated
600
$21.09K
0.8%
RLMD RELMADA THERAPEUTICS, INC.
25 Jan 2021
CEO
Sold, plan not stated
1,300
$45.88K
1.7%
RLMD RELMADA THERAPEUTICS, INC.
22 Jan 2021
CEO
Sold, plan not stated
2,170
$77.21K
2.7%
ATNM Actinium Pharmaceuticals, Inc.
15 Apr 2016
Director
Bought
1,000
$2.02K
50.0%
ATNM Actinium Pharmaceuticals, Inc.
14 Apr 2016
Director
Bought
2,000
$4.04K
opened
RLMD RELMADA THERAPEUTICS, INC.
15 Dec 2015
Chief Executive Officer
Bought
18,970
$57.79K
5.9%
RLMD RELMADA THERAPEUTICS, INC.
14 Dec 2015
Chief Executive Officer
Bought
30
$89.10
0.0%
36 decisions on file.